Action | 21 Jul 2026 02:11:41 ET │ 10 pages Telix Pharmaceuticals Ltd (TLX.AX) Removing Upside 30-Day Catalyst Watch We are closing our catalyst watch on Telix following an ahead of VA consensus 2Q sales print, although the shares were little moved. | Buy / High Risk | | | --- | --- | | Price (20 Jul 26 16:00) | A$15.10 | | Target price | A$31.00 | | Expected share price return | 105.3% | | Expected dividend yield | 0.0% | | Expected total return | 105.3% | | Market Cap | A$5,131M | | | US$3,598M | Laura Su ...